Evaluation of prescribing practices: Risk of lactic acidosis with metformin therapy

Archives of Internal Medicine

Volumn 162, Issue 4, 2002, Pages 434-437

  Calabrese, Amy T ^a   Coley, Kim C ^a   Dapos, Stacey V ^a   Swanson, Dennis ^a   Rao, R Harsha ^b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c Speakers Bureau of Bristol Mayer Squibb   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METFORMIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG CONTRAINDICATION; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 0037169941     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.4.434     Document Type: Article

References (11)

1. Pharmacologic therapy for type 2 diabetes mellitus
2. Drug therapy: Metformin
3. Contraindications to metformin therapy in patients with NIDDM
4. Contraindications to metformin therapy are largely disregarded
5. Lactic acidosis in patients with diabetes treated with mettormin
6. Role of metformin accumulation in metformin-associated lactic acidosis
7. Lactic acidosis rates in type 2 diabetics
8. Rhode Island physicians' recognition and reporting of adverse drug reactions
9. How many deaths are due to medical errors?
10. Drug labeling revisions: Guaranteed to fail?